VIRAX BIOLABS GROUP LTD
Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.
Latest price
$1.21
-8.33%
Yahoo Finance · 10/30/2026
One-year price history
Adjusted daily closes · 252 observations · as of Oct 30, 2026
1 month
-46.0%
3 months
-58.8%
6 months
-63.3%
1 year
-91.8%
Year to date
-86.0%
52-week range
$1.19 – $17.20
Fundamental snapshot
Latest reported period: Mar 31, 2026
Market cap
$700K
P/E
-0.1
P/B
0.1
P/S
58.3
Revenue
$12.42K
Net income
-$5.02M
Diluted EPS
-12.64
Gross margin
61.90%
Net margin
-40439.10%
Return on equity
-75.70%
Total debt
$414.39K
Cash
$6.44M
Free cash flow
-$4.88M
Latest eight reported quarters
Reported quarterly values, newest first
| Period | Revenue | Net income | Gross margin | Net margin | Free cash flow |
|---|---|---|---|---|---|
| Mar 31, 2026 | — | — | — | — | — |
| Sep 30, 2025 | — | — | — | — | — |
| Mar 31, 2025 | — | — | — | — | — |
| Sep 30, 2024 | — | — | — | — | — |
| Mar 31, 2024 | — | — | — | — | — |
| Sep 30, 2023 | — | — | — | — | — |
| Mar 31, 2023 | — | — | — | — | — |
| Sep 30, 2022 | — | — | — | — | — |
Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.
Recent VRAX news
All market newsNo ticker-linked stories are in the current archive.